GMP Inspection Trends Observed in Recent FDA Reports
GMP Inspection Trends Observed in Recent FDA Reports Recent Trends in FDA GMP Inspections: Key Observations and Compliance Focus Each year, the US Food and Drug Administration (FDA) releases a wealth of data on GMP inspection findings, including Form 483 observations, enforcement actions, and emerging areas of regulatory concern. These insights help pharmaceutical manufacturers proactively…
Read More “GMP Inspection Trends Observed in Recent FDA Reports” »